Loading…
Emerinopathy and laminopathy clinical, pathological and molecular features of muscular dystrophy with nuclear envelopathy in Japan
Mutations in the genes for nuclear envelope proteins of emerin (EMD) and lamin A/C (LMNA) are known to cause Emery-Dreifuss muscular dystrophy (EDMD) and limb girdle muscular dystrophy (LGMD). We compared clinical features of the muscular dystrophy patients associated with mutations in EMD (emerinop...
Saved in:
Published in: | Acta myologica 2007-12, Vol.26 (3), p.159-164 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | 164 |
container_issue | 3 |
container_start_page | 159 |
container_title | Acta myologica |
container_volume | 26 |
creator | Astejada, M N Goto, K Nagano, A Ura, S Noguchi, S Nonaka, I Nishino, I Hayashi, Y K |
description | Mutations in the genes for nuclear envelope proteins of emerin (EMD) and lamin A/C (LMNA) are known to cause Emery-Dreifuss muscular dystrophy (EDMD) and limb girdle muscular dystrophy (LGMD). We compared clinical features of the muscular dystrophy patients associated with mutations in EMD (emerinopathy) and LMNA (laminopathy) in our series. The incidence of laminopathy was slightly higher than that of emerinopathy. The age at onset of the disease in emerinopathy was variable and significantly older than in laminopathy. The initial symptom of emerinopathy was also variable, whereas nearly all laminopathy patients presented initially with muscle weakness. Calf hypertrophy was often seen in laminopathy, underscoring the importance of mutation screening for LMNA in childhood muscular dystrophy with calf hypertrophy. The clinical spectrum of emerinopathy is actually wider than previously known including EDMD, LGMD, conduction defects with minimal muscle/joint involvement, and their intermittent forms. Pathologically, no marked difference was observed between emerinopathy and laminopathy. Increased number and variation in size of myonuclei were detected. More precise observations using electron microscopy is warranted to characterize the detailed nuclear changes in nuclear envelopathy. |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2949309</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70133563</sourcerecordid><originalsourceid>FETCH-LOGICAL-p179t-58e4f40d7e896269cbff0359b2dc162b40fb7651e4b3b9b4b4af2ecb349db3a33</originalsourceid><addsrcrecordid>eNpVkM1OwzAQhHMA0ar0FZBPnIiU2I4TX5BQVf5UiQucI9tZt0aOHeykqFeenJSWCvaymtnVN9KcJdM8x1WKKcsmyTzG92wcShkv8EUyyStGWcGKafK1bCEY5zvRb3ZIuAZZ0Z60ssYZJewN2mtv_Xqvft5ab0ENVgSkQfRDgIi8Ru0QD2azi33w3cj4NP0GuUFZGG1wW7BHuHHoWXTCXSbnWtgI8-OeJW_3y9fFY7p6eXha3K3SLi95nxYVUE2zpoSKM8y4klpnpOASNypnWNJMy5IVOVBJJJdUUqExKEkobyQRhMyS2wO3G2QLjQLXB2HrLphWhF3than_X5zZ1Gu_rTGnnGR8BFwfAcF_DBD7ujVRgbXCgR9iXWY5IQXbJ139TTpF_NZOvgGY0YP5</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70133563</pqid></control><display><type>article</type><title>Emerinopathy and laminopathy clinical, pathological and molecular features of muscular dystrophy with nuclear envelopathy in Japan</title><source>PubMed Central</source><creator>Astejada, M N ; Goto, K ; Nagano, A ; Ura, S ; Noguchi, S ; Nonaka, I ; Nishino, I ; Hayashi, Y K</creator><creatorcontrib>Astejada, M N ; Goto, K ; Nagano, A ; Ura, S ; Noguchi, S ; Nonaka, I ; Nishino, I ; Hayashi, Y K</creatorcontrib><description>Mutations in the genes for nuclear envelope proteins of emerin (EMD) and lamin A/C (LMNA) are known to cause Emery-Dreifuss muscular dystrophy (EDMD) and limb girdle muscular dystrophy (LGMD). We compared clinical features of the muscular dystrophy patients associated with mutations in EMD (emerinopathy) and LMNA (laminopathy) in our series. The incidence of laminopathy was slightly higher than that of emerinopathy. The age at onset of the disease in emerinopathy was variable and significantly older than in laminopathy. The initial symptom of emerinopathy was also variable, whereas nearly all laminopathy patients presented initially with muscle weakness. Calf hypertrophy was often seen in laminopathy, underscoring the importance of mutation screening for LMNA in childhood muscular dystrophy with calf hypertrophy. The clinical spectrum of emerinopathy is actually wider than previously known including EDMD, LGMD, conduction defects with minimal muscle/joint involvement, and their intermittent forms. Pathologically, no marked difference was observed between emerinopathy and laminopathy. Increased number and variation in size of myonuclei were detected. More precise observations using electron microscopy is warranted to characterize the detailed nuclear changes in nuclear envelopathy.</description><identifier>ISSN: 1128-2460</identifier><identifier>PMID: 18646565</identifier><language>eng</language><publisher>Italy: Pacini Editore SpA</publisher><subject>DNA - genetics ; Humans ; Japan - epidemiology ; Lamin Type A - genetics ; Lamin Type A - metabolism ; Lipodystrophy ; Membrane Proteins - genetics ; Membrane Proteins - metabolism ; Muscular Dystrophies - epidemiology ; Muscular Dystrophies - genetics ; Muscular Dystrophies - metabolism ; Mutation ; Nuclear Envelope - genetics ; Nuclear Envelope - metabolism ; Nuclear Proteins - genetics ; Nuclear Proteins - metabolism ; Polymerase Chain Reaction ; Prevalence ; The Japanese–French Workshop</subject><ispartof>Acta myologica, 2007-12, Vol.26 (3), p.159-164</ispartof><rights>Copyright 1981 by Gaetano Conte Academy, Napoli 2007</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2949309/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2949309/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,53789,53791</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18646565$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Astejada, M N</creatorcontrib><creatorcontrib>Goto, K</creatorcontrib><creatorcontrib>Nagano, A</creatorcontrib><creatorcontrib>Ura, S</creatorcontrib><creatorcontrib>Noguchi, S</creatorcontrib><creatorcontrib>Nonaka, I</creatorcontrib><creatorcontrib>Nishino, I</creatorcontrib><creatorcontrib>Hayashi, Y K</creatorcontrib><title>Emerinopathy and laminopathy clinical, pathological and molecular features of muscular dystrophy with nuclear envelopathy in Japan</title><title>Acta myologica</title><addtitle>Acta Myol</addtitle><description>Mutations in the genes for nuclear envelope proteins of emerin (EMD) and lamin A/C (LMNA) are known to cause Emery-Dreifuss muscular dystrophy (EDMD) and limb girdle muscular dystrophy (LGMD). We compared clinical features of the muscular dystrophy patients associated with mutations in EMD (emerinopathy) and LMNA (laminopathy) in our series. The incidence of laminopathy was slightly higher than that of emerinopathy. The age at onset of the disease in emerinopathy was variable and significantly older than in laminopathy. The initial symptom of emerinopathy was also variable, whereas nearly all laminopathy patients presented initially with muscle weakness. Calf hypertrophy was often seen in laminopathy, underscoring the importance of mutation screening for LMNA in childhood muscular dystrophy with calf hypertrophy. The clinical spectrum of emerinopathy is actually wider than previously known including EDMD, LGMD, conduction defects with minimal muscle/joint involvement, and their intermittent forms. Pathologically, no marked difference was observed between emerinopathy and laminopathy. Increased number and variation in size of myonuclei were detected. More precise observations using electron microscopy is warranted to characterize the detailed nuclear changes in nuclear envelopathy.</description><subject>DNA - genetics</subject><subject>Humans</subject><subject>Japan - epidemiology</subject><subject>Lamin Type A - genetics</subject><subject>Lamin Type A - metabolism</subject><subject>Lipodystrophy</subject><subject>Membrane Proteins - genetics</subject><subject>Membrane Proteins - metabolism</subject><subject>Muscular Dystrophies - epidemiology</subject><subject>Muscular Dystrophies - genetics</subject><subject>Muscular Dystrophies - metabolism</subject><subject>Mutation</subject><subject>Nuclear Envelope - genetics</subject><subject>Nuclear Envelope - metabolism</subject><subject>Nuclear Proteins - genetics</subject><subject>Nuclear Proteins - metabolism</subject><subject>Polymerase Chain Reaction</subject><subject>Prevalence</subject><subject>The Japanese–French Workshop</subject><issn>1128-2460</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNpVkM1OwzAQhHMA0ar0FZBPnIiU2I4TX5BQVf5UiQucI9tZt0aOHeykqFeenJSWCvaymtnVN9KcJdM8x1WKKcsmyTzG92wcShkv8EUyyStGWcGKafK1bCEY5zvRb3ZIuAZZ0Z60ssYZJewN2mtv_Xqvft5ab0ENVgSkQfRDgIi8Ru0QD2azi33w3cj4NP0GuUFZGG1wW7BHuHHoWXTCXSbnWtgI8-OeJW_3y9fFY7p6eXha3K3SLi95nxYVUE2zpoSKM8y4klpnpOASNypnWNJMy5IVOVBJJJdUUqExKEkobyQRhMyS2wO3G2QLjQLXB2HrLphWhF3than_X5zZ1Gu_rTGnnGR8BFwfAcF_DBD7ujVRgbXCgR9iXWY5IQXbJ139TTpF_NZOvgGY0YP5</recordid><startdate>200712</startdate><enddate>200712</enddate><creator>Astejada, M N</creator><creator>Goto, K</creator><creator>Nagano, A</creator><creator>Ura, S</creator><creator>Noguchi, S</creator><creator>Nonaka, I</creator><creator>Nishino, I</creator><creator>Hayashi, Y K</creator><general>Pacini Editore SpA</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>200712</creationdate><title>Emerinopathy and laminopathy clinical, pathological and molecular features of muscular dystrophy with nuclear envelopathy in Japan</title><author>Astejada, M N ; Goto, K ; Nagano, A ; Ura, S ; Noguchi, S ; Nonaka, I ; Nishino, I ; Hayashi, Y K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p179t-58e4f40d7e896269cbff0359b2dc162b40fb7651e4b3b9b4b4af2ecb349db3a33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>DNA - genetics</topic><topic>Humans</topic><topic>Japan - epidemiology</topic><topic>Lamin Type A - genetics</topic><topic>Lamin Type A - metabolism</topic><topic>Lipodystrophy</topic><topic>Membrane Proteins - genetics</topic><topic>Membrane Proteins - metabolism</topic><topic>Muscular Dystrophies - epidemiology</topic><topic>Muscular Dystrophies - genetics</topic><topic>Muscular Dystrophies - metabolism</topic><topic>Mutation</topic><topic>Nuclear Envelope - genetics</topic><topic>Nuclear Envelope - metabolism</topic><topic>Nuclear Proteins - genetics</topic><topic>Nuclear Proteins - metabolism</topic><topic>Polymerase Chain Reaction</topic><topic>Prevalence</topic><topic>The Japanese–French Workshop</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Astejada, M N</creatorcontrib><creatorcontrib>Goto, K</creatorcontrib><creatorcontrib>Nagano, A</creatorcontrib><creatorcontrib>Ura, S</creatorcontrib><creatorcontrib>Noguchi, S</creatorcontrib><creatorcontrib>Nonaka, I</creatorcontrib><creatorcontrib>Nishino, I</creatorcontrib><creatorcontrib>Hayashi, Y K</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Acta myologica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Astejada, M N</au><au>Goto, K</au><au>Nagano, A</au><au>Ura, S</au><au>Noguchi, S</au><au>Nonaka, I</au><au>Nishino, I</au><au>Hayashi, Y K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Emerinopathy and laminopathy clinical, pathological and molecular features of muscular dystrophy with nuclear envelopathy in Japan</atitle><jtitle>Acta myologica</jtitle><addtitle>Acta Myol</addtitle><date>2007-12</date><risdate>2007</risdate><volume>26</volume><issue>3</issue><spage>159</spage><epage>164</epage><pages>159-164</pages><issn>1128-2460</issn><abstract>Mutations in the genes for nuclear envelope proteins of emerin (EMD) and lamin A/C (LMNA) are known to cause Emery-Dreifuss muscular dystrophy (EDMD) and limb girdle muscular dystrophy (LGMD). We compared clinical features of the muscular dystrophy patients associated with mutations in EMD (emerinopathy) and LMNA (laminopathy) in our series. The incidence of laminopathy was slightly higher than that of emerinopathy. The age at onset of the disease in emerinopathy was variable and significantly older than in laminopathy. The initial symptom of emerinopathy was also variable, whereas nearly all laminopathy patients presented initially with muscle weakness. Calf hypertrophy was often seen in laminopathy, underscoring the importance of mutation screening for LMNA in childhood muscular dystrophy with calf hypertrophy. The clinical spectrum of emerinopathy is actually wider than previously known including EDMD, LGMD, conduction defects with minimal muscle/joint involvement, and their intermittent forms. Pathologically, no marked difference was observed between emerinopathy and laminopathy. Increased number and variation in size of myonuclei were detected. More precise observations using electron microscopy is warranted to characterize the detailed nuclear changes in nuclear envelopathy.</abstract><cop>Italy</cop><pub>Pacini Editore SpA</pub><pmid>18646565</pmid><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1128-2460 |
ispartof | Acta myologica, 2007-12, Vol.26 (3), p.159-164 |
issn | 1128-2460 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2949309 |
source | PubMed Central |
subjects | DNA - genetics Humans Japan - epidemiology Lamin Type A - genetics Lamin Type A - metabolism Lipodystrophy Membrane Proteins - genetics Membrane Proteins - metabolism Muscular Dystrophies - epidemiology Muscular Dystrophies - genetics Muscular Dystrophies - metabolism Mutation Nuclear Envelope - genetics Nuclear Envelope - metabolism Nuclear Proteins - genetics Nuclear Proteins - metabolism Polymerase Chain Reaction Prevalence The Japanese–French Workshop |
title | Emerinopathy and laminopathy clinical, pathological and molecular features of muscular dystrophy with nuclear envelopathy in Japan |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T11%3A51%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Emerinopathy%20and%20laminopathy%20clinical,%20pathological%20and%20molecular%20features%20of%20muscular%20dystrophy%20with%20nuclear%20envelopathy%20in%20Japan&rft.jtitle=Acta%20myologica&rft.au=Astejada,%20M%20N&rft.date=2007-12&rft.volume=26&rft.issue=3&rft.spage=159&rft.epage=164&rft.pages=159-164&rft.issn=1128-2460&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E70133563%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p179t-58e4f40d7e896269cbff0359b2dc162b40fb7651e4b3b9b4b4af2ecb349db3a33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=70133563&rft_id=info:pmid/18646565&rfr_iscdi=true |